Furthermore, increased amounts of insulin, insulin-like growth factor-1 (IGF-1) and IGF-binding proteins are detected in the sera and tissues of pancreatic cancer patients12–14 and promote tumour growth, metastasis and chemoresistance12,15–18. Here, IGF1 is linked to pancreatic neoplasm.